View More Recent Stories

Mar 20, 2023 07:58AM NurExone Biologic Reports Additional Positive Preclinical Trial Outcomes with ExoPTEN: 75% of Paralyzed Rats Show Recovery after Acute Spinal Cord Injury Study
Feb 17, 2023 08:00AM NurExone Announces Interim Positive Results of Internal Preclinical Study of Proprietary ExoPTEN Drug
Jan 13, 2023 03:00PM United States Patent Office Allows Patent to Exosome Biomedical Company Nurexone
Feb 12, 2014 10:00AM NephroGenex [NRX] to Ring The NASDAQ Stock Market Opening Bell in Celebration of Recent IPO
Feb 11, 2014 12:23PM NASDAQ Welcomes NephroGenex (NASDAQ:NRX) to The NASDAQ Stock Market
View More Recent Stories